Skip to main content Skip to section navigation Skip to footer
Stock Information
chevron_left Back to CastleBiosciences.com
Castle Biosciences, Inc. IR Home
  • Overview
  • News & Events keyboard_arrow_down
    • Press Releases
    • IR Events
    • Presentations
    • In The Media
    • Annual Meeting
    • Email Alerts
  • Company Info keyboard_arrow_down
    • Company Profile
    • Executive Team
    • Annual Reports & Proxy
    • Contacts
    • FAQ
  • Financial Info keyboard_arrow_down
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data keyboard_arrow_down
    • Quote & Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings keyboard_arrow_down
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance keyboard_arrow_down
    • Governance Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Corporate Responsibility
  • Resources keyboard_arrow_down
    • Scientific Evidence
  • Stock Information
  • chevron_leftBack to CastleBiosciences.com

In The Media

News & Events

  • Press Releases
  • IR Events
  • Presentations
  • In The Media
  • Annual Meeting
  • Email Alerts
Jul 1, 2025
Dermatology Times: Gene Expression Profiling Guides Individualized Management in Melanoma and SCC
Jul 1, 2025
Oswego County Today: Oswego Health Medical Practice Adopts Advanced Test to Predict Esophageal Cancer Risk
Jun 30, 2025
Houston Business Journal reveals 2025 Most Admired CEO honorees
Jun 25, 2025
USA Today: Early Detection Can Save Lives: How a Precision Medicine Test May Help Predict the Development of Esophageal Cancer
Jun 25, 2025
Future of Personal Health (Digestive Health & Diseases independent supplement by Mediaplanet to USA Today): Early Detection Can Save Lives: How a Precision Medicine Test May Help Predict the Development of Esophageal Cancer
Jun 24, 2025
The Gut Doctor Podcast: Food as Medicine: The GERD diet with Dillon Martin, RDN
Jun 18, 2025
OncLive: DecisionDx®-Melanoma is Designed to Identify Cutaneous Melanoma Patients Who Can Safely Forgo Sentinel Lymph Node Biopsy Without Experiencing Early Recurrence
Jun 18, 2025
Dermatology Times: DecisionDx®-SCC Informs Adjuvant Radiation Therapy Treatment Decisions for Patients with Cutaneous Squamous Cell Carcinoma
Jun 17, 2025
360Dx: Castle Biosciences Licenses SciBase Technology for New Dermatologic Disease Test Development
Jun 17, 2025
Gastro Girl Podcast: Barrett’s Esophagus: What Patients Need to Know to Take Action, an interview with Tedra Gray, MSN, APRN, ACNP-BC
rss_feed RSS
  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • …
  • Page 26
  • Next Pagearrow_forward
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed
©2026 Castle Biosciences, Inc. All Rights Reserved.
  • Privacy Policy
  • Disclaimer
  • Sitemap
  • Accessibility Statement

Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.